EP2712617
Meðhöndlun á trefjun með því að nota Fxr-bindla
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
14.3.2005EP published:
2.11.2016EP application number:
13189553.4
EP translation filed:
30.11.2016Grant published:
15.12.2016EPO information:
European Patent Register
Max expiry date:
13.3.2025Expiry date:
13.3.2022
Title:
Treatment of fibrosis using Fxr ligands
Timeline
Today
14.3.2005EP application
2.11.2016EP Publication
30.11.2016Translation submitted
15.12.2016Registration published
13.3.2022Expires
Owner
Name:
Intercept Pharmaceuticals, Inc.Address:
421 Hudson Street, Suite 212, 10014, New York, NY, US
Inventor
Name:
Fiorucci, StefanoAddress:
Perugia, IT
Name:
Pelliciari, RobertoAddress:
Perugia, IT
Name:
Pruzanski, MarkAddress:
NY, NY New York, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
552865 PDate:
12.3.2004Country:
US
Classification
Categories:
A61K 31/56
Annual fees
Number
Paid
Expires
Payer
Number: 13
Paid: 20.2.2017
Expires: 13.3.2018
Payer: Sigurjónsson & Thor ehf.
Number: 14
Paid: 20.2.2018
Expires: 13.3.2019
Payer: Sigurjónsson & Thor ehf.
Number: 15
Paid: 19.2.2019
Expires: 13.3.2020
Payer: Sigurjónsson & Thor ehf.
Number: 16
Paid: 26.2.2020
Expires: 13.3.2021
Payer: Sigurjónsson & Thor ehf.
Number: 17
Paid: 18.2.2021
Expires: 13.3.2022
Payer: Sigurjónsson & Thor ehf.